Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Knowing when to revise your retirement strategy is key to staying on track. Learn the indicators that signal it's time for an adjustment.
21,255 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Headline-grabbing insider sales can feel alarming, but the true driver of stock performance is deal flow. Learn to se...
As U.S. markets navigate mixed inflation data and a cautious Fed stance, dividends remain a focal point. This report ...
Artificial intelligence is remaking markets. This guide explains why leaders Nvidia, Palantir, and Meta matter for in...
Netflix has chased big bets beyond subscribers, but the road from ambition to profits is rocky. This article breaks d...
RE/MAX brokers are turning to repeatable systems over lofty goals to push growth amid market shifts, with panels at R...
February delivered a sharp move for Iren Limited as the market wrestled with a bold pivot from neocloud mining to AI ...
Snowflake stock down hard has sparked headlines and worries about growth. But the core platform—cross‑cloud data ware...
As of mid-May 2026, two retail ETFs diverge sharply: RTH climbs on mega-cap strength, while XRT drifts lower with a b...
In May, walmart stock dropped 12% despite solid earnings. This in-depth look breaks down the drivers behind the decli...
As Disney readies Toy Story 5, investors wonder if this beloved IP can spark a broader upswing. This piece breaks dow...
Alibaba stock rallying today is drawing traders' eyes as AI optimism and cloud demand lift sentiment. This article br...